Barely Significant
← all excerpts

Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.

J Am Heart Assoc · 2018 · PMC5850234 · PMID 29367415

Europe PMCDOI
2
hedged sentences
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

did not reach statistical significanceP =0.10so close (0.05 < p ≤ 0.1)
Although there was a trend toward decreased heart weight with ADAMTS13 treatment compared with vehicle treatment, this did not reach statistical significance ( P =0.10 by Mann‐Whitney U test).

also in 111,027 other papers

highly significantno p-value reported
Reduction was highly significant at the highest dose of 3460 U/kg, whereas the lowest dose of 40 U/kg had no effect (Figure 2 B).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.